JCVI-syn3A Minimal Cell
Insulin Release
HIV Vaccine
Caulobacter Polar Microdomain
Collagen and Extracellular Matrix
Escherichia coli Bacterium
Myoglobin in a Whale Muscle Cell
Cellulose Synthase
CytoSkeleton
Transfer RNA and Gag Protein
RecA and DNA
Casein Micelle and Fat Globule in Milk
Model of a Mycoplasma Cell
Phage-based COVID-19 Vaccine
Myelin
Immunological Synapse
SARS-CoV-2 Fusion
Red Blood Cell Cytoskeleton
SARS-CoV-2 and Neutralizing Antibodies
Respiratory Droplet
Coronavirus
SARS-CoV-2 mRNA Vaccine
Coronavirus Life Cycle
Influenza Vaccine
Measles Virus Proteins
Lipid Droplets
Poliovirus Neutralization
Excitatory and Inhibitory Synapses
Abiogenesis
Last Universal Common Ancestor
Zika Virus
Insulin Action
Ebola Virus
Mycoplasma mycoides
Chloroplast
Autophagy
Vascular Endothelial Growth Factor (VegF) Signaling
Biosites: Muscle
Biosites: Basement Membrane
Biosites: Red Blood Cell
Biosites: Nucleus
Biosites: Blood Plasma
Biosites: Cytoplasm
Blood
Escherichia coli
HIV in Blood Plasma

Molecular Landscapes by David S. Goodsell

HIV Vaccine, 2022

Acknowledgement: David S. Goodsell, RCSB Protein Data Bank and Scripps Research. doi: 10.2210/rcsb_pdb/goodsell-gallery-043

This painting shows a new approach to designing vaccines, termed "germline-targeting." The vaccine challenges the immune system with several levels of glycosylation on the vaccine molecule: specific glycans that obscure an epitope are removed from the immunogen, which primes the immune system. In subsequent vaccinations, the glycans are restored to simulate a mature/native protein. Here, a solubilized version of HIV envelope glycoprotein (magenta) is used for the vaccine, and two levels of glycosylation are shown: one fully-glycosylated and one with glycans removed at the receptor-binding site. The glycans that are removed are shown in slightly darker magenta. The vaccine glycoproteins are binding to B-cell receptors (Y-shaped molecules in yellow-green) on the surface of a B-cell (membrane in green, cytoplasm in blue) and activating many signaling proteins inside the cell (shown in blue-green on the inner side of the membrane). Blood plasma is at top, with Y-shaped antibodies in yellow.

Painting created in collaboration with T. G. Caniels in the laboratory of Rogier Sanders at University of Amsterdam and Amsterdam UMC.